For: | Gebauer N, Schmidt-Werthern C, Bernard V, Feller AC, Keck T, Begum N, Rades D, Lehnert H, Brabant G, Thorns C. Genomic landscape of pancreatic neuroendocrine tumors. World J Gastroenterol 2014; 20(46): 17498-17506 [PMID: 25516664 DOI: 10.3748/wjg.v20.i46.17498] |
---|---|
URL: | https://www.wjgnet.com/1007-9327/full/v20/i46/17498.htm |
Number | Citing Articles |
1 |
Bhavina D.O. Batukbhai, Ana De Jesus-Acosta. The Molecular and Clinical Landscape of Pancreatic Neuroendocrine Tumors. Pancreas 2019; 48(1): 9 doi: 10.1097/MPA.0000000000001189
|
2 |
Alberto Puccini, Kelsey Poorman, Mohamed E. Salem, Davide Soldato, Andreas Seeber, Richard M. Goldberg, Anthony F. Shields, Joanne Xiu, Francesca Battaglin, Martin D. Berger, Ryuma Tokunaga, Madiha Naseem, Afsaneh Barzi, Syma Iqbal, Wu Zhang, Shivani Soni, Jimmy J. Hwang, Philip A. Philip, Stefania Sciallero, W. Michael Korn, John L. Marshall, Heinz-Josef Lenz. Comprehensive Genomic Profiling of Gastroenteropancreatic Neuroendocrine Neoplasms (GEP-NENs). Clinical Cancer Research 2020; 26(22): 5943 doi: 10.1158/1078-0432.CCR-20-1804
|
3 |
Vinod Vijayakurup, Kyungah Maeng, Hye Seung Lee, Benjamin Meyer, Sandra Burkett, Akbar Nawab, Michael W. Dougherty, Christian Jobin, Iqbal Mahmud, Timothy J. Garrett, Michael Feely, Kyoung Bun Lee, Frederic J. Kaye, Maria V. Guijarro, Maria Zajac-Kaye. Thymidylate synthase accelerates Men1-mediated pancreatic tumor progression and reduces survival. JCI Insight 2022; 7(19) doi: 10.1172/jci.insight.147417
|
4 |
Ahmed Ibrahim Samir Khalil, Costerwell Khyriem, Anupam Chattopadhyay, Amartya Sanyal. Hierarchical discovery of large-scale and focal copy number alterations in low-coverage cancer genomes. BMC Bioinformatics 2020; 21(1) doi: 10.1186/s12859-020-3480-3
|
5 |
George Fotopoulos, Ioannis Vathiotis, George C. Nikou, Konstantinos Syrigos. The Role of Genetics in Sporadic GEP-NETs: A Comprehensive Review of the Literature. Forum of Clinical Oncology 2017; 8(1): 1 doi: 10.1515/fco-2017-0001
|
6 |
David R. Martin, Elisa LaBauve, Joseph M. Pomo, Vi K. Chiu, Joshua A. Hanson, Rama R. Gullapalli. Site-Specific Genomic Alterations in a Well-Differentiated Pancreatic Neuroendocrine Tumor With High-Grade Progression. Pancreas 2018; 47(4): 502 doi: 10.1097/MPA.0000000000001030
|
7 |
Xin Lou, Yi Qin, Xiaowu Xu, Xianjun Yu, Shunrong Ji. Spatiotemporal heterogeneity and clinical challenge of pancreatic neuroendocrine tumors. Biochimica et Biophysica Acta (BBA) - Reviews on Cancer 2022; 1877(5): 188782 doi: 10.1016/j.bbcan.2022.188782
|
8 |
Daniela Regazzo, Mattia Barbot, Carla Scaroni, Nora Albiger, Gianluca Occhi. The pathogenic role of the GIP/GIPR axis in human endocrine tumors: emerging clinical mechanisms beyond diabetes. Reviews in Endocrine and Metabolic Disorders 2020; 21(1): 165 doi: 10.1007/s11154-019-09536-6
|
9 |
Jin-Zhi Xu, Wen-Quan Wang, Shi-Rong Zhang, Hua-Xiang Xu, Chun-Tao Wu, Zi-Hao Qi, He-Li Gao, Quan-Xing Ni, Liang Liu, Xian-Jun Yu. Intrinsic Contact Between T and N Classifications in Resected Well–Moderately Differentiated Locoregional Pancreatic Neuroendocrine Neoplasms. Annals of Surgical Oncology 2018; 25(3): 647 doi: 10.1245/s10434-017-6289-1
|
10 |
Hayley Vaughn, Heather Major, Evangeline Kadera, Kendall Keck, Timothy Dunham, Qining Qian, Bartley Brown, Aaron Scott, Andrew M. Bellizzi, Terry Braun, Patrick Breheny, Dawn E. Quelle, James R. Howe, Benjamin Darbro. Functional Copy-Number Alterations as Diagnostic and Prognostic Biomarkers in Neuroendocrine Tumors. International Journal of Molecular Sciences 2024; 25(14): 7532 doi: 10.3390/ijms25147532
|
11 |
Timon Vandamme, Matthias Beyens, Ken Op de Beeck, Fadime Dogan, Peter M van Koetsveld, Patrick Pauwels, Geert Mortier, Christel Vangestel, Wouter de Herder, Guy Van Camp, Marc Peeters, Leo J Hofland. Long-term acquired everolimus resistance in pancreatic neuroendocrine tumours can be overcome with novel PI3K-AKT-mTOR inhibitors. British Journal of Cancer 2016; 114(6): 650 doi: 10.1038/bjc.2016.25
|
12 |
K Luley, J. Gebauer, N. Gebauer, L. Tharun, I. Buchmann, J. Barkhausen, N. von Bubnoff, K. Lindner, T. Keck, H. Lehnert, S. M. Schmid. Gastroenteropankreatische neuroendokrine Neoplasien – Heterogenität, Management und Perspektiven der Versorgung und Forschung. Der Internist 2020; 61(8): 875 doi: 10.1007/s00108-020-00832-x
|
13 |
Teresa Starzyńska, Jakub Karczmarski, Agnieszka Paziewska, Maria Kulecka, Katarzyna Kuśnierz, Natalia Żeber-Lubecka, Filip Ambrożkiewicz, Michał Mikula, Beata Kos-Kudła, Jerzy Ostrowski. Differences between Well-Differentiated Neuroendocrine Tumors and Ductal Adenocarcinomas of the Pancreas Assessed by Multi-Omics Profiling. International Journal of Molecular Sciences 2020; 21(12): 4470 doi: 10.3390/ijms21124470
|
14 |
Praveen Dilip Chatani, Sunita Kishore Agarwal, Samira Mercedes Sadowski. Molecular Signatures and Their Clinical Utility in Pancreatic Neuroendocrine Tumors. Frontiers in Endocrinology 2021; 11 doi: 10.3389/fendo.2020.575620
|
15 |
Judy S. Crabtree. Clinical and Preclinical Advances in Gastroenteropancreatic Neuroendocrine Tumor Therapy. Frontiers in Endocrinology 2017; 8 doi: 10.3389/fendo.2017.00341
|
16 |
Tobias Hofving, Yvonne Arvidsson, Bilal Almobarak, Linda Inge, Roswitha Pfragner, Marta Persson, Göran Stenman, Erik Kristiansson, Viktor Johanson, Ola Nilsson. The neuroendocrine phenotype, genomic profile and therapeutic sensitivity of GEPNET cell lines. Endocrine-Related Cancer 2018; 25(3): 367 doi: 10.1530/ERC-17-0445
|
17 |
Chi-Chih Kang, Toby M. Ward, Jessica Bockhorn, Courtney Schiffman, Haiyan Huang, Mark D. Pegram, Amy E. Herr. Electrophoretic cytopathology resolves ERBB2 forms with single-cell resolution. npj Precision Oncology 2018; 2(1) doi: 10.1038/s41698-018-0052-3
|